Uncategorized

FDA approves Pfizer’s RSV vaccine for adults at increased risk of the disease – CNBC

Posted on Author Comments Off on FDA approves Pfizer’s RSV vaccine for adults at increased risk of the disease – CNBC

FDA approves Pfizer’s RSV vaccine for adults at increased risk of the disease  CNBCPfizer Receives FDA Approval for RSV Vaccine  The Wall Street JournalWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK’s Arexvy. But will it amount to much?  FiercePharmaPfizer’s RSV vaccine cleared by FDA for use in some younger adults  Yahoo FinanceHealthCentral: Which RSV Vaccine Is Right for You?  Cedars-Sinai